H A R E S I G N

Primary care management consulting for GP practices and PCNs across England. IGPM Accredited Member.

Contact Info
Email

[email protected]

Connect

LinkedIn

Primary care consulting for GP practices & PCNs across England. Get in touch →

Get In Touch

Safety Alert

Class 4 Medicines Defect Notification: Renacet 475 mg and 950 mg Tablets (calcium acetate), RenaCare NephroMed GmbH, EL(25)A15

Published
7 April 2025
Source
Alerts and Recalls for Drugs and Medical Devices - General Practice
Imported
6 Jun 2026
Original alert
https://www.gov.uk/drug-device-alerts/c…
RenaCare NephroMed GmbH has informed the MHRA of the presence of an undeclared excipient in the coating of the tablets. This excipient is Macrogol 6000, which has always been included in Renacet Tablets but has been omitted …
View Original Alert
Important: This alert is aggregated automatically for information only. Always refer to the original source and follow your practice's own clinical governance procedures.
About this source
Alerts and Recalls for Drugs and Medical Devices - General Practice
All alerts from this source
More from Alerts and Recalls for Drugs and M…
MHRA Safety Roundup: January 2026 27 Jan 2026
M6-C Artificial Cervical Disc, Spinal Kinetics LLC: New monitoring requirements for the r… 15 Jan 2026
MHRA Safety Roundup: December 2025 18 Dec 2025
MHRA Safety Roundup: November 2025 27 Nov 2025
MHRA Safety Roundup: October 2025 28 Oct 2025
Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.
View this week's digest

Back to Safety Alerts